| Kimber, Ian (Syngenta UK 200601) |
n. a. |
Syngenta (Group) |
Switzerland |
| Kimura, Alan (CureVac 202002– Head of Rare Diseases before Enzyvant + SutroVax + Translate Bio + Shire + Novartis) |
President/Director/Head Business Group/Unit/Division |
CureVac (Group) |
Germany |
| Kimura, Keiji (Sony 201109 EVP + Executive Officer Sony Corp) |
Board member, executive |
Sony (Group) |
Japan |
| Kindervater, Ralf (BioPro 200503 Managing Director) |
Managing Director |
Baden-Württemberg (govt region) |
Germany |
| Kindler, Constanze (Qiagen 200705 Product Manager) |
Product Manager (personnel) |
Qiagen (Group) |
Germany |
| King, David P. (LabCorp 201707 CEO before COO joined 2001) |
Chief Executive Officer (CEO) |
LabCorp (Group) |
United States (USA) |
| King, Gary (Myriad 201501 EVP International Operations) |
n. a. |
Myriad Genetics (Group) |
United States (USA) |
| Kinsella, Kevin J. (Avalan Ventures 201506 Founder) |
Company Founder |
Avalon Ventures |
United States (USA) |
| Kintzel, Wolfgang (Ayoxxa 201802 Managing Director + Science to Market Venture Capital + CEVEC Pharmaceuticals + Direvo) |
Managing Director |
Ayoxxa (Group) |
Germany |
| Kipp, Bryan (PerkinElmer 201902 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
PerkinElmer (Group) |
United States (USA) |
| Kiprijanov, Sergej (Affitech 200802– Head of Research before Novoplant) |
Research & Development Manager |
Affitech (Group) |
Norway |
| Kirby, Leo (Baker Brothers 201108) |
n. a. |
Baker Brothers (Group) |
United States (USA) |
| Kirchheim, Ansgar (High-Tech Gründerfonds 201603 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Kirchhoff, Marcus (MeVis Medical Solutions 201203– CEO before GE Healthcare IT) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
Germany |
| Kirchhoff, Petra (Sartorius 201401 VP Group Corporate Communications + IR) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
| Kirchhoff, Tobias (BCNP Consultants GmbH 201612 Senior Consultant) |
Consultant (economic/technology) |
BCNP Consultants GmbH |
Germany |
| Kirchmair, Johannes (Single Use Support 201911 Managing Director + Co-Founder) |
n. a. |
Single Use Support GmbH (SUS) |
Austria |
| Kirchner, Christian (Wallinger Ricker Schlotter Trastmann 201409 Patent Attorney) |
Patent Attorney |
Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte (WRST) |
Germany |
| Kirchner, Hellmut |
Managing Partner (investment firm) |
Sal. Oppenheim jr & Cie. KGaA |
Germany |
| Kirchrath, Lutz (NuGEN 200904– Managing Director Europe before Affymetrix Europe before Amersham Pharmacia Freiburg) |
Managing Director |
Tecan (Group) |
United States (USA) |
| Kirk, Chris (SGS 201011 CEO) |
Chief Executive Officer (CEO) |
SGS (Group) |
Switzerland |
| Kirk, Randal J. (Intrexon 201502 CEO) |
Chief Executive Officer (CEO) |
Halozyme Therapeutics Inc. (Nasdaq: HALO) |
United States (USA) |
| Kirkwood, Karen (Thermo Fischer 201202 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Thermo Fisher (Group) |
United States (USA) |
| Kirn, David (4D Molecular Therapeutics 201804 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
4D Molecular Therapeutics LLC (4DMT) |
United States (USA) |
| Kiron, Ravi (KineMed 201401 CBO) |
Chief Business Officer (CBO) |
KineMed Inc. |
United States (USA) |
| Kirsch, Harry (Novartis 201304– Group CFO before CFO of Novartis Pharmaceuticals) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Kirsch, Heidrun (MolecularHealth 201405 Molecular Health GmbH) |
n. a. |
Molecular Health (Group) |
Germany |
| Kirschbaum, Bernhard (Merck Serono 200809 Executive VP Research) |
Research & Development Manager |
Merck (DE) (Group) |
Germany |
| Kirschenhofer, Florian (Max Planck 201509 Startup + Portolio Manager at Max Planck Innovation) |
IP Manager |
Max Planck Society for the Advancement of Science |
Germany |
| Kirst, Oliver (Servier 201711 General Manager of Servier Germany) |
General Manager (management) |
Servier (Group) |
Germany |
| Kissel, Karsten (Boehringer 201711 Head Global Medical Affairs Biosimilars) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Kitschin, Dana (Israel (govt) 201110 Israel Trade Center Berlin) |
n. a. |
Israel (govt) |
Germany |
| Kjøller, Kim (Leo Pharma 201201 SVP Global Development) |
Research & Development Manager |
Leo Pharma (Group) |
Denmark |
| Klaften, Matthias (Amcure GmbH 201202– Managing Director + Co-founder) |
Managing Director |
Amcure GmbH |
Germany |
| Klann, Günter (Omnilab (D) 200903 Managing Director) |
Managing Director |
Omnilab (DE) (Group) |
Germany |
| Klapproth, Peter (Microstim 201309 Managing Director + Co-founder) |
Managing Director |
Microstim GmbH |
Germany |
| Klaue, Daniel (Zellmechanik Dresden 202011 Managing Director) |
Managing Director |
Zellmechanik Dresden GmbH |
Germany |
| Klaue, Thomas (Injex Pharma AG 201312 CEO) |
Chief Executive Officer (CEO) |
Injex Pharma AG |
Germany |
| Klaus, Uwe (Saxonia BioTec 200411 Managing Director) |
Managing Director |
Saxonia BioTec GmbH |
Germany |
| Klauschen, Frederick (Charité 202008 Prof + Deputy Director of Institute of Pathology) |
Professor |
Humboldt University Berlin |
Germany |
| Klausener, Alexander (Bayer 201112 Head of Research at Bayer CropScience) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Klausner, Richard (Rick) (Lyell Immunopharma 201910 CEO + Founder before Juno Therapeutics + NCI) |
Chief Executive Officer (CEO) |
Lyell Immunopharma, Inc. |
United States (USA) |
| Klebe, Martin (Univ Marburg 201502 Professor) |
Professor |
University of Marburg (Philipps-Universität Marburg) |
Germany |
| Klebl, Bert (Lead Discovery Center 200806– CEO) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Kleczkowska, Hanna (Helsinn 201709 Helsinn Investment Fund) |
Investment Manager |
Helsinn (Group) |
Luxembourg |
| Kleemann, Axel (Asta Medica 1987–2000 before Degussa ua) |
Board member |
Æterna Zentaris (Group) |
Germany |
| Klein, Christoph (Univ Regensburg 201902 + Fraunhofer ITEM 201902) |
Researcher (university / research institute) |
University of Regensburg |
Germany |
| Klein, David Benshoof (Click Therapeutics 202009 CEO) |
Chief Executive Officer (CEO) |
Click Therapeutics Inc. |
United States (USA) |
| Klein, Frank-P. (Definiens 200811 VP Medical Imaging) |
n. a. |
AstraZeneca (Group) |
Germany |
| Klein, Hanns-Georg (IMGM 201008 Managing Director + Dr Klein & Dr Rost 201008 CEO) |
Managing Director |
IMGM Laboratories GmbH |
Germany |
| Klein, Jens (AMSilk GmbH –201607–202012 CEO LEFT 1/21) |
Chief Executive Officer (CEO) |
AMSilk GmbH |
Germany |
| Klein, Thomas (Cytolon 2011 CEO + Founder before Noxxon 1997– CEO + Founder) |
Chief Executive Officer (CEO) |
Cytolon AG |
Germany |
| Klein, Udo (Bruker 200904 Managing Director + minority owner RI Research Instruments GmbH) |
Managing Director |
Bruker (Group) |
Germany |
| Klein, Wolfgang (Therapy Invest Group 2012 founder before CureVac CFO) |
Company Founder |
Therapy Invest Group (Group) |
Germany |
| Kleinert, Rainer (Bioserv Diagnostics GmbH 201111 Managing Director) |
Managing Director |
Bioserv Diagnostics GmbH |
Germany |
| Kleinfeld, Klaus (Siemens 200606 CEO) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Kleinhammer, Aljoscha (IMGM Laboratories GmbH 201408 Sales + Marketing Coordinator) |
Sales Manager / Marketing Manager |
IMGM Laboratories GmbH |
Germany |
| Kleinhammer, Christian |
n. a. |
Deutsche Gesellschaft für Proteomforschung (DGPF) |
Germany |
| Kleist, Karin (Sartorius 201302 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Sartorius (Group) |
Germany |
| Kleschick, David (Dow 201307 Discovery Global Leader at Dow AgroSciences) |
Research & Development Manager |
Dow Chemical (Group) |
United States (USA) |
| Kley, Imme (CMS 201508 Attorney at CMS Hasche Sigle Hamburg advising life sciences + med tech firms) |
Attorney / Lawyer |
CMS (Group) |
Germany |
| Kley, Karl-Ludwig (Merck D 200705– Executive Chairman + CEO TO RETIRE 4/6) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Klie, Sebastian (Targenomix GmbH 201404 Managing Director) |
Managing Director |
Targenomix GmbH |
Germany |
| Klimek, Susanne (Salvator Vermögensverwaltungs GmbH 201101 Managing Director) |
Managing Director |
Salvator Vermögensverwaltungs GmbH |
Germany |
| Kline, Robert (ViroCyt 201607 CEO) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
United States (USA) |
| Klingan, Franz-Robert (Bain & Co 201610 Partner) |
Consultant (economic/technology) |
Bain & Company |
|
| Klingauf, Jürgen (Univ Münster 201007 Professor Institute for Medical Physics and Biophysics) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Klingberg, Andreas (Univ Hamburg + OpenChrom 201308) |
n. a. |
University of Hamburg |
Germany |
| Klinger, Jörn (Beroceutica GmbH 201606– Managing Director + Co-Founder) |
Managing Director |
Beroceutica GmbH |
Germany |
| Klinger, Olaf (Merck Serono S.A. 200701 CFO) |
Chief Financial Officer (CFO) |
Merck (DE) (Group) |
Switzerland |
| Klinger, Olaf (Symrise 201902 CFO) |
Chief Financial Officer (CFO) |
Symrise (Group) |
Germany |
| Klinger, Shannon Thyme (Novartis 2018– Group General Counsel before Chief Ethics, Risk + Compliance Officer joined 2011) |
General Counsel / Chief Legal Officer (CLO) |
Novartis (Group) |
Switzerland |
| Klingner, Gabriele (BioM 201904 Manager Communications + Training) |
Public Relations Manager / Investor Relations Manager |
Bavaria (govt region) |
Germany |
| Klinkmann, Horst (Kuratorium Gesundheitswirtschaft des Landes Mecklenburg-Vorpommern 201106 President) |
Professor |
Mecklenburg-Vorpommern (govt region) |
Germany |
| Kliphuis, Edward (Amadeus Capital 202009– Partner before M Ventures + Kempen & Co) |
Partner (venture partner) |
Amadeus Capital (Group) |
United Kingdom (GB) |
| Klocker, Martina (Biocrates 201110 Marketing Manager) |
Sales Manager / Marketing Manager |
Biocrates (Group) |
Austria |
| Kloke, Lutz (Cellbricks GmbH 201608– Managing Director + Founder) |
Managing Director |
Cellbricks GmbH |
Germany |
| Kloos, Robert (Germany (govt) 201011 Staatssekretär BMELV) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Klopfer, Julia (Greiner Bio-One 200504) |
n. a. |
Greiner (Group) |
Germany |
| Klose, Joachim |
n. a. |
Humboldt University Berlin |
Germany |
| Klosk, Steven M. (Cambrex 200708 Exec VP + COO) |
Chief Executive Officer (CEO) |
Cambrex (Group) |
United States (USA) |
| Kloss, Michael (Bayer 201506 Global Head of Bayer Diabetes Care) |
President/Director/Head Business Group/Unit/Division |
PHC (Group) |
United States (USA) |
| Klosterkemper, Bernd (Ananda Ventures 201908) |
Investment Manager |
Ananda Ventures GmbH (Ananda Impact Ventures) |
Germany |
| Klostermann, Andreas (ConoGenetix 201204 Managing Director + Co-founder) |
Managing Director |
ConoGenetix Biosciences GmbH |
Germany |
| Kloth, Stefan (Osteolabs GmbH 201803– Managing Director + Co-Founder) |
Managing Director |
Osteolabs GmbH |
Germany |
| Klug, Cornelia (High-Tech Gründerfonds 201805 Public Relations Manager) |
Public Relations Manager / Investor Relations Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Kluge, Peter (Qiagen 201205 Senior Sales Manager DE + AT + CH + NL for Ipsogen) |
Sales Manager / Marketing Manager |
Qiagen (Group) |
Germany |
| Kluge, Ulrike (Klugeconcepts 201610 Managing Director before Schwarz Pharma + Schering + Helopharm + Merrell Dow) |
Managing Director |
Klugeconcepts GmbH |
Germany |
| Klußmann, Sven (Aptarion Biotech 201608– CEO before Noxxon CSO) |
Chief Executive Officer (CEO) |
Aptarion Biotech AG |
Germany |
| Klühr, Felix (Holtzbrinck 20210 at HV Holtzbrinck Ventures) |
n. a. |
Holtzbrinck (Group) |
Germany |
| Klysner, Steen (Amarna Therapeutics 202009– CEO before ExpreS2ion Biotech + Allergopharma + Nordic Vaccine + Pharmexa) |
Chief Executive Officer (CEO) |
Amarna Therapeutics B.V. |
Netherlands |
| Klüwer, Arne (Dentons 202005 Partner at Frankfurt Office) |
Attorney / Lawyer |
Dentons (Group) |
Germany |
| Klöck, Gerd (Hochschule Bremen 201103 Professor Bioprocess Engineering before ttz Bremerhaven) |
Professor |
University of Applied Sciences Bremen (Hochschule Bremen) |
Germany |
| Klöpper, Christof (Basel (govt) 201702 CEO of BaselArea.swiss) |
Chief Executive Officer (CEO) |
Basel (govt city) |
Switzerland |
| Klöpper, Norbert (Bruker 201411 Head of ETD business) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
United States (USA) |
| Knabbe, Cornelius (Prof in addit 2006 Eppendorf SAB) |
Advisory Board member |
Eppendorf (Group) |
Germany |
| Knabe, Hans-Jürgen (Metrohm 201107 Managing Director Methrom Gmbh & Co KG RETIRED 12/12) |
Managing Director |
Metrohm (Group) |
Germany |
| Knauer, Alexandra (Knauer 201402 Managing Director) |
Managing Director |
Knauer (Group) |
Germany |
| Knauer, Annette |
n. a. |
Eurofins (Group) |
Germany |
| Knauer, Sascha (Sulfotools GmbH 201603– Managing Director + Co-Founder) |
Managing Director |
Sulfotools GmbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 32 33 34 ... 73 74 75 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
